SPRINT PNS System

FDA 510(k) K240974 · Spr Therapeutics, Inc.

Substantially Equivalent

510(k) numberK240974

Submission

Device name
SPRINT PNS System
Applicant
Spr Therapeutics, Inc.
Cleveland, OH, US
Received
April 10, 2024
Decision date
April 14, 2026
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
SCN – Temporarily Implanted Peripheral Nerve Stimulation System For Sustained Pain Relief
Device class
Class II (moderate risk)
Regulation
21 CFR 882.5870
Specialty
Neurology
Implant
Yes

A temporarily implanted peripheral nerve stimulation system for sustained pain relief is a prescription device that uses an external electrical stimulator(s) and percutaneous electrode(s) to stimulate a peripheral nerve(s) to provide sustained pain relief after the end of treatment.

More from Spr Therapeutics, Inc.

510(k)DeviceDecision
K223306SPRINT Peripheral Nerve Stimulation (PNS) SystemNHI · Traditional 01/25/2023SE
K211801SPRINT PNS SystemNHI · Traditional 10/13/2021SE
K202660SPRINT PNS SystemNHI · Traditional 01/22/2021SE
K181422SPRINT Peripheral Nerve Stimulation System, Extensa, SPRINT Peripheral Nerve Stimulation…NHI · Traditional 07/31/2018SE
K170902Sprint System, Single Procedure Kit, Sprint System with Pad II, Single Procedure Kit…NHI · Traditional 06/26/2017SE
K161154Smartpatch PNS MicroLead and Accessories, Smartpatch PNS Stimulator, Pads, and…NHI · Traditional 07/23/2016SE

Questions and answers

When was SPRINT PNS System cleared by the FDA?

SPRINT PNS System (K240974) received a 510(k) decision of Substantially Equivalent on April 14, 2026, 734 days after the submission was received.

What is the product code of K240974?

The FDA product code is SCN – Temporarily Implanted Peripheral Nerve Stimulation System For Sustained Pain Relief, a Class II (moderate risk) device regulated under 21 CFR 882.5870.